全部股東
股東類型
- 機構投資者46.89%
- 創投/私募31.99%
- 公眾及其他18.93%
- 個人與內幕人士2.19%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
TCG Crossover Management, LLC | 10.47% | 567.31 萬 | -- | +567.31 萬 | 31/03/2026 |
RA Capital Management, L.P. | 8.31% | 450.19 萬 | 1.67% | -90.31 萬 | 16/07/2026 |
Forbion Capital Partners B.V. | 7.60% | 411.74 萬 | 1.74% | +50.00 萬 | 31/03/2026 |
VR Management, LLC | 5.61% | 304.17 萬 | 0.59% | +109.80 萬 | 31/03/2026 |
Frazier Life Sciences Management, LP | 4.69% | 254.39 萬 | 1.88% | +0 | 31/03/2026 |
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited | 3.69% | 199.99 萬 | 1.47% | +0 | 31/03/2026 |
Caligan Partners, LP | 3.55% | 192.51 萬 | 1.16% | +100.00 萬 | 31/03/2026 |
Great Point Partners, LLC | 3.23% | 175.00 萬 | 0.31% | +37.99 萬 | 31/03/2026 |
Paradigm Biocapital Advisors LP | 3.23% | 175.00 萬 | 1.29% | +0 | 31/03/2026 |
FMR LLC | 2.84% | 153.97 萬 | 3.68% | -98.65 萬 | 31/03/2026 |
Vanguard Capital Management, LLC | 2.65% | 143.33 萬 | -- | +143.33 萬 | 31/03/2026 |
Reid Hoffman | 2.15% | 116.69 萬 | 0.86% | +0 | 21/10/2025 |
Marshall Wace LLP | 2.13% | 115.33 萬 | -- | +115.33 萬 | 31/03/2026 |
State Street Global Advisors, Inc. | 2.06% | 111.85 萬 | 1.83% | +102.74 萬 | 31/03/2026 |
Nextbio Capital Management LP | 1.85% | 100.00 萬 | 0.74% | +0 | 31/03/2026 |
BlackRock, Inc. | 1.47% | 79.48 萬 | 0.26% | +32.91 萬 | 31/03/2026 |
Logos Global Management, L.P. | 1.38% | 75.00 萬 | 1.13% | +65.00 萬 | 31/03/2026 |
Rosalind Advisors, Inc. | 1.29% | 70.00 萬 | -- | +70.00 萬 | 31/03/2026 |
Nan Fung Trinity (HK) Limited | 1.19% | 64.66 萬 | -- | +64.66 萬 | 30/06/2026 |
Boothbay Fund Management, LLC | 1.03% | 55.57 萬 | -- | +55.57 萬 | 31/03/2026 |